Landscape Capital Management, L.L.C. Catalent, Inc. Transaction History

Landscape Capital Management, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 08, 2019	SELL	$39.26 - $54.21 $451,961 - $624,065	-11,512 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$29.84 - $43.92 $18,083 - $26,615	-606 Reduced 5.0%	11,512 $467,000
Q4 2018 Feb 14, 2019	SELL	$29.95 - $46.34 $394,082 - $609,741	-13,158 Reduced 52.06%	12,118 $378,000
Q3 2018 Nov 14, 2018	BUY	$40.12 - $45.55 $1.01 Million - $1.15 Million	25,276 New	25,276 $1.15 Million

509

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Landscape Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Landscape Capital Management, L.L.C. with notifications on news.